| Sanofi and Teva to Collaborate on Inflammatory Bowel Disease Treatment |
Abstract
pdf
html
|
|
Lalit Mishra |
|
| Roche Signs US$2 B Partnership with Monte Rosa for Molecular Glue Medicines |
Abstract
pdf
html
|
|
Amit Kaushik |
|
| Genentech Pays Orionis US$47 M Upfront for Molecular Glue Medicines |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Roche Partners with Ionis for RNA-Targeting Neurology Programmes |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| GSK Signs US$1.5 B ADC Licensing Pact with Hansoh Pharma |
Abstract
pdf
html
|
|
Lalit Mishra |
|
| Bristol Myers Squibb to Acquire Mirati Therapeutics for Up to US$5.8 B |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| Eli Lilly to Acquire Point Biopharma to Strengthen its Oncology Portfolio |
Abstract
pdf
html
|
|
Shweta Gupta |
|
| Kyowa Kirin to Acquire Orchard Therapeutics for US$477.6 M |
Abstract
pdf
html
|
|
Ayush Saxena |
|
| Alfasigma to Acquire Intercept Pharmaceuticals to Expand into Liver Diseases |
Abstract
pdf
html
|
|
Amit Kaushik |
|
| Novo Nordisk to Acquire Ocedurenone for Hypertension from KBP Biosciences |
Abstract
pdf
html
|
|
Lalit Mishra |
|
| Roche Pays US$7.1 B for Bowel Disease Drug from Roivant and Pfizer |
Abstract
pdf
html
|
|
Lucy Haggerty |
|
| GSK Partners with Zhifei to Boost Shingrix® in China |
Abstract
pdf
html
|
|
Shweta Gupta |
|
| IQVIA Pharma Deals Half-Year Review of 2023 |
Abstract
pdf
|
|
Lucy Haggerty,Swati Sharan & Taskin Ahmed |
|
